Sentences with phrase «studying patient safety»
Researchers studying patient safety in states with «caps» (like Texas) found «consistent evidence that patient safety generally falls» after caps are enacted.
http://www.thepoptort.com/ Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Presentations will highlight the short and long - term effects of Ingrezza on tardive dyskinesia symptoms by body region, long term safety and efficacy data from the KINECT 4 phase 3 open label study and also from RE-KINECT (real - world screening study of patients with possible TD).
Whether or not the problems are huge, at least someone goes to the trouble of identifying and quantifying them (e.g., the new study in the Journal of Patient Safety — a whole freakkin» journal devoted to safety, who Safety — a whole freakkin» journal devoted to safety, who safety, who knew?)
In response to reports that women may be using this unapproved drug, to increase milk production (lactation), the WHO and FDA are warning breastfeeding women of safety concerns as «there have been several published reports and case studies of cardiac arrhythmias, cardiac arrest and sudden death in patients receiving an intravenous form of domperidone that has been withdrawn from the market in a number of countries.»
In order to protect infant safety and ensure the patient and human rights of mothers and babies, we have built a non-profit organization committed to: (1) the study of exclusive breastfeeding complications that can result in brain injury and, in the most severe instances, death; and (2) raising public awareness to signs of infant hunger and the consequences that can result based on peer - reviewed research.
As mentioned already the «Centre for policy studies» has said that the NHSLA has liabilities of some # 16.8 billion, reducing this figure would make huge inroads to the efficiency saving the NHS has to make without compromising patient safety and staff numbers It would be wise for those within the NHS and from the «Centre for policy studies» to look to their own as for the reason why patients look to the law for recompense, before we say that the compensation culture is «ingrained in the national psyche as a warped form of normal behaviour».
«While the small - scale study suggests that beta - blockers may reduce the risk of breast cancer returning, more research is needed in this area to determine the effectiveness and safety of the treatment before it can be routinely offered to breast cancer patients.
Further studies in animal models and patients (with altered TRPM7 channel function) have been initiated, in order to evaluate the efficacy and safety of magnesium as a therapeutic for this disease.
Specifically, at the end of the study period, all 15 patients appeared to have a favorable safety profile and to be generally well tolerated.
The grant was to study what types of computational systems, in conjunction with physiological patient monitors, could be implemented into vehicles to achieve the safety objective.
The NAPOLI - 1 (NAnoliPOsomaL Irinotecan) Phase 3 study — a final confirmation of a drug's safety and effectiveness — was conducted among patients with metastatic pancreatic cancer who previously received gemcitibine, which has been the standard - of - care therapy for such patients.
The largest urban health systems, which serve as safety nets for large patient populations with lower socioeconomic status and greater likelihood to speak English as a second language, do worse on government patient satisfaction scores than smaller, non-urban hospitals likely to serve white customers with higher education levels, according to a new study by Mount Sinai researchers published this month in the Journal of Hospital Medicine.
For example, the results of one study, known as UPLIFT, one of four large - scale studies conducted in 2008, demonstrated the effectiveness and safety of a drug called Spirivain about 6,000 patients with respiratory disease.
«The results from the exenatide studies justify continued testing, but clinicians and patients are urged not to add exenatide to their regimens until more is known about their safety and impact on Parkinson's.»
Following the success of this preliminary safety and feasibility study, more patients are being recruited for a larger clinical trial of the procedure to test the efficacy and durability of the procedure.
To help our patients suffering from this disorder, we need to gather reliable data to evaluate the effectiveness and safety profile of new treatment options,» said lead study author Liang Zheng from the department of gastroenterology, the Second Jiangsu Provincial Hospital of Chinese Medicine, Nanjing University of Chinese Medicine.
Apart from patient testimonials and a few preliminary studies in tumor cell lines and in mice, critics say, there is no evidence of the safety or efficacy of the compound, popularly known as the «cancer pill» or «fosfo.»
Many patients and physicians assume that the safety and effectiveness of newly approved drugs is well understood by the federal Food and Drug Administration (FDA)-- but a new study by researchers at Yale School of Medicine shows that the clinical trials used by the FDA to approve new drugs between 2005 and 2012 vary widely in their thoroughness.
The imaging software — developed and currently in use only at Cincinnati Children's — mathematically determines the lowest possible radiation dose for the patient before a scan is performed, according to the study led by David Larson, MD, radiology quality and safety director at the medical center and principal architect of the technology.
«While Massachusetts safety - net hospitals (many of which are minority - serving) received large cuts in payments with the idea that other hospitals would assume the care of previously uninsured patients, this study demonstrates the importance of securing the future of safety - net and minority - serving hospitals through policy - based interventions to assure the continued care of vulnerable and underserved patient populations.»
Of the 10 patients enrolled in the study — a clinical trial designed to evaluate safety and feasibility — none of the participants experienced any dangerous side effects and one patient's disease remained stable after 18 months.
Because bazedoxifene has already undergone safety and efficacy studies as a treatment for osteoporosis, it may be a viable near - term option for patients with advanced breast cancer whose tumors have become resistant to other treatment options, Wardell reported.
The data safety monitoring board of the trial, as mandated by the study protocol, continues to monitor outcomes in patients with a Recurrence Score of 11 to 25 randomized to chemo - endocrine therapy or endocrine therapy alone.
Lisa K. McIntyre, M.D., of the University of Washington Medical Center, Seattle, and colleagues conducted a study that included 173 general surgical patients (91 men) who were identified as being unplanned readmissions within 30 days among 2,100 discharges (8 percent) at a Level I trauma center and safety - net hospital.
«Currently, most victims of elder abuse and neglect pass through our emergency departments with a life - threatening condition unidentified,» said the latter paper's lead study author, Tony Rosen, MD, MPH, of Weill Cornell Medical College in New York, N.Y. «A multi-disciplinary, team - based approach supported by additional research and funding has the potential to improve the identification of elder abuse and improve the health and safety of our most vulnerable patients.»
This study utilized the National Electronic Injury Surveillance System (NEISS) database, which is managed by the Consumer Product Safety Commission (CPSC) and collects information on emergency room patients from 100 U.S. hospitals.
The hospital's new surgical patient safety program, which aligned with NSQIP best practices, quickly resulted in «a dramatic reduction» of SSIs, said Rael Klein, MD, FRCP, a study coauthor and an anesthesiologist at the University of British Columbia, Vancouver.
Dr Richard Booton, Consultant Respiratory Physician at the North West Lung Centre and senior lecturer at the University's Institute of Inflammation and Repair who led the study, said: «We wanted to see if there were any differences between patients aged less than 70 years old and those older than 70, in terms of both the safety of the technique and how useful it was for diagnosis.
For the new study, Saint and his colleagues from the Patient Safety Enhancement Program, a joint U-M and VA program, surveyed infection control leaders at hospitals, as part of an ongoing project that started in 2005.
TIDE, currently taking place worldwide, was designed to provide rigorous evidence about the drug's safety, and the designers of the study had plans to enroll up to 15,000 more diabetes patients.
The safety study sets the stage for phase II clinical trials looking at whether high dose vitamin C is effective at extending overall lifespan and quality of life for patients undergoing radiation and chemotherapy.
His team is winding up a safety study in which 40 patients breathed in a single dose of a lipid - CFTR DNA mixture.
In a study published online by JAMA Cardiology, Fredrik Björck, M.D., of Umea University, Umea, Sweden and colleagues evaluated the efficacy and safety of well - managed warfarin therapy in patients with nonvalvular atrial fibrillation.
As part of the approval, the manufacturer must conduct a five year post approval study that will follow at least 100 patients and collect additional safety and effectiveness data including weight loss, adverse events, surgical revisions and explants and changes in obesity - related conditions.
As part of the Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS), that started in 2004, the researchers followed 215 adult patients, with chronic non-cancer pain, who used medical cannabis, and compared them to a control group of 216 chronic pain sufferers who were not cannabis users.
Promising outcomes of preliminary studies in patients in Southeast Asia and parts of Western and Central Africa led the World Health Organization to make the recommendation, but safety and efficacy have not yet been proven in large - scale clinical trials.
We hope to move from the safety study into a full scale efficacy study in the spring, involving more patients in centres around the UK and Europe.
To make his point, Representative Andy Harris (R — MD) points to the $ 1.37 billion that NIH spends each year on health services research and $ 1 billion for studies of patient safety (both listed here).
In a six - month open - label study of patients receiving T - sol, published in The Journal of Urology ®, researchers noted improvement of low sex drive and low energy symptoms, and did not identify new safety concerns.
Professor Justin Cobb, Chief Investigator, said: «In this safety study, we are ensuring that the H1 hip resurfacing implant can be used safely on patients needing hip replacement surgery.
A Canadian research team led by Dr. Mark Ware from the Research Institute of the McGill University Health Centre (RI - MUHC) in Montréal has completed a national multicentre study looking at the safety of medical cannabis use among patients suffering from chronic pain.
«Study allays concerns over aspirin's safety for heart failure patients.»
Our study is one of the largest to explore the efficacy and safety of anti-TNF therapy in a large independent cohort of JDM patients.»
Because almost 70 percent of its patients are the victims of motor vehicle crashes, automobile safety is a major focus of study at the center.
«Across specialties and across the country the rate of compliance has been extremely poor,» says the study's lead author Christopher Landrigan, a sleep and patient safety researcher at Brigham and Women's Hospital at Harvard.
In addition to Dr. Aminian, study authors of the abstract entitled, «A Nationwide Safety Analysis of Bariatric Surgery in Nonmorbidly Obese Patients with Type 2 Diabetes,» include John Kirwan, PhD; Bartolome Burguera, MD, PhD; Stacy Brethauer, MD; and Philip Schauer, MD, all from Cleveland Clinic.
Studies presented today at The International Liver Congress ™ 2016 in Barcelona, Spain, demonstrate that tenofovir alafenamide (TAF) improves patient safety while maintaining efficacy in patients with chronic Hepatitis B virus (HBV) infection compared to tenofovir disoproxil fumarate (Viread, TDF).
The study's findings raise «serious concerns about patient safety» and reveal an «urgent need for greater regulation and oversight in medical app development,» the authors say.
In an effort to reduce the incidence of complications and improve patient safety, a secondary goal of the study was to identify risk factors associated with each complication to produce formal practice advisories or guideline recommendations.